Von Willebrand Disease
📧 Sign up to get email alerts when something new happens for Von Willebrand Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD) [Phase 1]
Phase 1 trial evaluating the pharmacokinetics, safety, and tolerability of efanesoctocog alfa (BIVV001) in adults with Von Willebrand diseas…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: The Lived Experience of People With Von Willebrand Disease
A completed Haemnet clinical trial update exploring the lived experiences of people with von Willebrand disease.
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD) [Phase 3]
A Phase 3 study evaluating recombinant von Willebrand factor (rVWF) in pediatric and adult participants with severe von Willebrand disease h…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)
Updates on the post-trial access program for TAK-577 in patients with Von Willebrand disease, outlining continued access after participation…
-
FDA approval · 2025-08-27FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Avenacy, Inc.)
FDA approved a supplemental application for Desmopressin Acetate by Avenacy, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) [Phase 1, Phase 2]
A clinical trial update for VGA039 in healthy volunteers and patients with Von Willebrand disease, spanning Phase 1/2 and currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: T-TAS® wS Method Comparison
This document reports the completed results of a T-TAS wS method comparison study conducted by Hikari Dx, Inc. The study involved Von Willeb…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) [Phase 3]
A Phase 3 study evaluating recombinant von Willebrand factor (rVWF) with or without ADVATE in children with severe von Willebrand disease is…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease [NA]
This ClinicalTrials.gov update reports the completion of a study evaluating transcutaneous auricular neurostimulation to reduce heavy menstr…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Effectiveness and Tolerability of Eqwilate in Real-life Conditions
This clinical trial update evaluates the real-world effectiveness and tolerability of Eqwilate for Von Willebrand disease, with the study cu…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Real-life Data of Constitutional Von Willebrand Disease in Western France
Completed real-world observational study of constitutional Von Willebrand disease in Western France using data from Nantes University Hospit…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease [NA]
A Lille hospital-sponsored clinical trial is testing an algorithm-based management approach to reduce recurrent GI bleeding and severe epist…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Molecular and Clinical Profile of Von Willebrand Disease in Spain
A completed clinical trial update focused on the molecular and clinical profile of Von Willebrand Disease in Spain.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: ATHN 9: Severe VWD Natural History Study
Update on ATHN 9, a natural history study of severe von Willebrand disease; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
A recruiting clinical trial in the French West region is studying cardiovascular and venous thromboembolism outcomes in patients with von Wi…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD [Phase 3]
Phase 3 pilot crossover trial comparing prophylactic Wilate to placebo for heavy menstrual bleeding in patients with von Willebrand disease;…
-
EMA approval · 2024-12-18EMA Authorised: Voncento (human coagulation factor VIII;human von willebrand factor) — CSL Behring GmbH
The EMA authorised Voncento, a Factor VIII/von Willebrand factor concentrate by CSL Behring, for treatment of Hemophilia A and von Willebran…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease [Phase 4]
Phase 4 clinical trial update on Fanhdi, a high-purity von Willebrand factor-containing FVIII concentrate, to assess efficacy and safety in …
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Minimize Menorrhagia in Women With Von Willebrand Disease [Phase 3]
A Phase 3 trial evaluating a treatment to reduce menorrhagia in women with von Willebrand disease has been terminated; results have been pos…
-
FDA approval · 2024-03-21FDA Approved: DESMOPRESSIN ACETATE — Original Application (Aurobindo Pharma Limited)
FDA approved desmopressin acetate from Aurobindo Pharma Limited under an original abbreviated new drug application (ANDA213095).
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
Clinical trial update reporting bleeding incidence in Von Willebrand disease patients receiving on-demand treatment; results posted after co…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD [Phase 3]
A phase 3 clinical trial evaluating Wilate for efficacy and safety as prophylaxis in previously treated patients with von Willebrand disease…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients [Phase 4]
Phase 4 trial update evaluating the efficacy of Alphanate FVIII/VWF concentrate in patients with Type 3 Von Willebrand Disease.
-
FDA approval · 2022-11-16FDA Approved: DESMOPRESSIN ACETATE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the Original Application for Desmopressin Acetate from Fresenius Kabi USA, LLC (ANDA216922). This marks the approval of a gener…
-
FDA approval · 2022-08-19FDA Approved: DESMOPRESSIN ACETATE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved Desmopressin Acetate from Dr. Reddy's Laboratories Inc. via an Original Application for a generic product.